---
gsd_state_version: 1.0
milestone: v3.3
milestone_name: Rituximab/Methotrexate-Associated Diagnoses of Interest
status: executing
stopped_at: Completed 131-02-PLAN.md
last_updated: "2026-07-22T20:14:26.753Z"
last_activity: 2026-07-22
progress:
  total_phases: 5
  completed_phases: 4
  total_plans: 12
  completed_plans: 10
---

# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-07-15 after v3.2)

**Core value:** A working cohort filter chain that reads like a clinical protocol — with logged attrition at every step and clear payer-stratified visualizations showing how patients flow from enrollment through diagnosis to treatment.

**Current focus:** Phase 131 — update-all-codes-resolved-xlsx-to-include-med-admin-ndc-resolved-codes-and-a-normalized-drug-name-column

## Current Position

Phase: 131 (update-all-codes-resolved-xlsx-to-include-med-admin-ndc-resolved-codes-and-a-normalized-drug-name-column) — EXECUTING
Plan: 02 of 4 complete
Status: Ready to execute (131-03 next)
Last activity: 2026-07-22

Progress: [████████░░] 83% (10/12 plans complete, v3.3 milestone)

## Performance Metrics

**Milestone velocity:**

- v3.2: 23 phases (104-126) completed (2026-06-15 to 2026-07-15)
- v3.1: 4 phases (100-103) completed in 1 day (2026-06-12)
- v3.0: 5 phases (95-99) completed in 3 days

**Planning efficiency:**

- Average plans per phase: 1.0 (recent milestones)
- Average tasks per plan: 3.0

## Accumulated Context

### v3.3 Roadmap Decisions

- Phase numbering continues from Phase 126 (v3.2 last phase) — v3.3 starts at Phase 127
- Granularity: coarse (4 phases for 19 requirements, following research's recommended 4-phase decomposition)
- Phase 127 (Code-Set & Infrastructure) is a strict prerequisite for all others: DOI_CODE_MAP + utils_doi.R must exist before any classification code is written
- Phase 128 (Classification) is a strict prerequisite for Phase 129 (Attribution): doi_encounters.rds must exist before attribution joins
- Phase 130 (Registration/Smoke Test) can begin once Phase 129's R/111 structure is stable; its HiPerGator runtime gate is the v3.3 definition-of-done
- DOI_ATTRIBUTION_WINDOW_DAYS = 90L (one clinical quarter) — wider than cancer cascade's ±30 days because RA/psoriasis/IBD indication timelines span months, not weeks
- Three-state likely_non_lymphoma_directed flag: NA must not be collapsed to FALSE (would undercount the clinically interesting ambiguous HL+DoI co-occurrence cases)
- DuckDB-native prefix filter mandatory: never load full DIAGNOSIS table into R (OOM risk on HiPerGator)
- I77.82 excluded (seed error — "Dissection of artery"), D47.Z2 excluded (CANCER_SITE_MAP conflict)
- utils_doi.R as new file (not extension of utils_cancer.R): classify_codes() has 10+ consumers expecting cancer-site output; merging would silently corrupt them

### Roadmap Evolution

- Phase 131 added: Update all_codes_resolved.xlsx to include MED_ADMIN NDC-resolved codes and a normalized drug-name column

### Phase 131 Decisions

- [Phase 131-01]: Reused Phase 120's R/105 col-G Supportive Care output in MEDICATION_LOOKUP (per-sheet `med_col` selector: col 7 when present, col 3 fallback) instead of re-deriving Supportive Care names via the new fallback normalizer
- [Phase 131-01]: Copied (not imported) R/105's `rule_based_ingredient()` strip logic and word lists into `fallback_normalize_medication()`, since R/105 is a one-time reference-Excel enrichment script, not a shared utility module
- [Phase 131-01]: `fallback_normalize_medication()`'s HCPCS and RxNorm-STR branches both route through `canonicalize_drug_name()` so fallback output stays consistent with MEDICATION_LOOKUP's brand->generic collapsing
- [Phase 131-02]: `get_chemo_hits()` gained an additive `return_source` param (default FALSE) tagging PRESCRIBING / MED_ADMIN (RX) / MED_ADMIN (NDC) / DISPENSING (NDC) rows; all 6 existing callers unaffected since none pass it
- [Phase 131-02]: R/50's RXNORM loop now queries PRESCRIBING + MED_ADMIN (RX+ND) + DISPENSING generically for all 4 RXNORM vectors (`filter(code_type == "RXNORM")`), with Records/Patients de-duplicated on `(ID, treatment_date, code)` — existing Records counts for multi-row-per-day codes will drop vs. prior `all_codes_resolved.xlsx` runs (intended Pitfall-2 fix, not a regression; flag to collaborators on next regeneration)

### Active TODOs

- [ ] Plan Phase 127 (Code-Set and Infrastructure Centralization)
- [ ] Execute Phase 131 Plan 03 (normalized drug-name column)

### Known Blockers

- Phase 131 requirement IDs (`MEDXLSX-01..05`) are referenced in 131-01/131-02 PLAN frontmatter but are not defined in `.planning/REQUIREMENTS.md` (no Phase 131 section exists there yet). `gsd-tools requirements mark-complete` cannot find/check them off. Not blocking execution, but the traceability table needs a Phase 131 section added before this can be closed out cleanly.

## Session Continuity

**Last command:** `/gsd:execute-phase 131` (2026-07-22)
**Stopped at:** Completed 131-02-PLAN.md
**What's next:** Execute 131-03 (normalized drug-name column), then 131-04 (verification/regeneration on HiPerGator).
